Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combined use of anti PD-1 and anti M-CSF antibodies in the treatment of cancer

Combined use of anti PD-1 and anti M-CSF antibodies in the treatment of cancer

US Patent 11001628 · Granted May 11, 2021

Estimated economic value: $115,479,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Variant IgG Fc polypeptides and uses thereof2024
Pharmaceutical combinations2022
1-(4-amino-5-bromo-6-(1H-pyrazol-1-yl)pyrimidin-2-yl)-1H-pyrazol-4-ol and use th2021
Compositions and methods of use for augmented immune response and cancer therapy2020
5-bromo-2,6-di-(1H-pyrazol-1-yl)pyrimidin-4-amine for use in the treatment of ca2020
Pharmaceutical combinations2019
Biomarkers for IAP inhibitor therapy2016
Combination therapy2015
Combination therapy2015